VIVIEN O TUCKER
Allopathic & Osteopathic Physicians|Family Medicine FAYETTEVILLE, AR NPI 1821049925
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AR Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$806.74
- Category: General Payments
- Program years: PY2018–2019
- Record count: 76
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $131.32 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $124.20 | 8 |
| Education | $7.12 | 1 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $33.42 | 3 |
| Amgen Inc. | $32.03 | 2 |
| Novo Nordisk AS | $21.62 | 1 |
| PFIZER INC. | $15.93 | 1 |
| Lilly USA, LLC | $14.68 | 1 |
| GlaxoSmithKline, LLC. | $13.64 | 1 |
By program year
Records — PY2019 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 658215743 | Lilly USA, LLC | $14.68 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 663161897 | Amgen Inc. | $18.02 | 03/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 663161899 | Amgen Inc. | $14.01 | 02/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669502555 | Novo Nordisk Inc | $21.62 | 03/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 670221739 | GlaxoSmithKline, LLC. | $13.64 | 02/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 673044953 | PFIZER INC. | $15.93 | 04/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 681786911 | Takeda Pharmaceuticals U.S.A., Inc. | $13.70 | 01/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 681791095 | Takeda Pharmaceuticals U.S.A., Inc. | $12.60 | 01/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 681983405 | Takeda Pharmaceuticals U.S.A., Inc. | $7.12 | 01/15/2019 | Education | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.